hematology & blood disorders

Download Hematology & Blood Disorders

Post on 04-Jan-2017

220 views

Category:

Documents

3 download

Embed Size (px)

TRANSCRIPT

  • Page 1

    Scientific Program

    OMICS Group Conferences5716 Corsa Ave., Suite 110, Westlake Los Angeles, CA 91362-7354, USA

    Phone: +1-650-268-9744, Fax: +1-650-618-1414, Toll free: +1-800-216-6499Email: hematology2014@omicsgroup.us

    Organize your Events at OMICS Group ConferencesProposals are invited for organizing Symposia/Workshops at OMICS Group Conferences or OMICS Group will sponsor small events at your universities in related areas under the title of your own. These proposals can be sent to respective conference mail ids or to symposia@omicsonline.org

    218th OMICS Group Conference

    September 29-October 01, 2014 DoubleTree by Hilton Baltimore-BWI Airport, USA

    2nd International Conference on

    Hematology & Blood Disorders

    Exhibitor

    Media Partners

  • Page 2

    08:30-09:30 RegistrationsChesa Peake

    Opening Ceremony09:30-10:00

    Day 1 September 29, 2014

    Session 1 Track 1: Hematologic Malignancies Track 2: Thrombosis and HemostasisSession Chair: Yi Ning, Johns Hopkins University, USASession Co-Chair: Jianchang Yang, Stony Brook University Medical Center, USA

    Session Introduction

    11:45-12:05Title: Heterogeneity of abnormal RUNX1 leading to clinicopathological variations in childhood B lymphoblastic leukemiaXiayuan Liang, University of Colorado, USA

    12:05-12:25Title: Cryptic t(11;17) is a recurrent translocation resulting in NUP98-PHF23 fusion that shares gene expression signatures of NUP98-HOXA9 fusion and leukemic stem cellsYi Ning, Johns Hopkins University, USA

    12:25-12:30 Group PhotoLunch Break 12:30-13:15 @ Edens Landing Restaurant

    13:15-13:35Title: AML with t (8;16) shows unique clinical, morphological and immunophenotypic featuresGabriela Gheorghe, Children's Hospital of Wisconsin, USA

    13:35-13:55Title: Molecular mechanisms of B lymphomagenesis induced by TRAF3 inactivationPing Xie, Rutgers University, USA

    13:55-14:15Title: Anaplastic large cell lymphoma, ALK-positive, small cell variant, with leukemic presentation and rare CD8-positive phenotypeDragos C Luca, Children's National Medical Center, USA

    14:15-14:35Title: Knockdown of SALL4 enhances All-trans Retinoic Acid (ATRA)- induced Acute Myeloid Leukemia (AML) cell differentiationJianchang Yang, Stony Brook University Medical Center, USA

    14:35-14:55Title: Cutaneous T cell lymphoma: A simulator of benign disease that requires clinical pathologic correlation to distinguish aggressive from indolent diseaseJacqueline M. Junkins-Hopkins, Ackerman Academy of Dermatopathology, USA

    14:55:15:15Title: The combination of FLT3 inhibition and hypomethylation confers synergistic anti-leukemic activity on FLT3/ITD positive AML cell lines and primary cellsHeiko Konig, Indiana University Simon Cancer Center, USA

    15:15-15:35Title: Neonatal alloimmune thrombpcytopeniaNoel K Strong, The Icahn School of Medicine, USA

    Coffee Break 15:35-15:55 @ Foyer

    15:55:16:15Title: HMTC-NB- Hematologic malignancies therapy and cardiotoxicity: New biomarkersAdel Gouri, IBN ZOHR Public Hospital, Algeria

    Keynote Forum10:00-10:10 Introduction10:10-10:35 E Brad Thompson University of Houston, USA

    Coffee Break 10:35-10:55 @ Foyer

    10:55-11:20 Mark Roschewski National Institutes of Health, USA11:20-11:45 Britt Gustafsson Center for Allogeneic Stem Cell Transplantation, Sweden

  • Page 3

    16:15-16:35Title: Expression of CD95 in acute lymphocytic leukemia in Egyptian children before and after treatmentJackleen Awadallah Raafat, National Research Center, Egypt

    16:35-16:55Title: Clinical manifestations in children with tonsillar lymphomaAlexandre Caixeta Guimaraes, University of Campinas, Brazil

    16:55-17:15Title: Acute reactives and markers of inflammation in venous thromboembolism disease: Clinical and evolution outcomesPablo Javier Marchena Yglesias, Parc Sanitari Sant Joan de Deu, Spain

    17:15-17:35Title: Efficacy and safety of low molecular weight heparin compared to unfractionated heparin for chronic outpatient hemodialysis in end stage renal disease: Systematic review and meta-analysisDinesh Keerty, The Wright Center for Graduate Medical Education, USA

    17:35-17:55Title: Effect of alcohol consumption on platelet, prothrombin time and activated partial thromboplastin time of alcoholics in Birnin Kebbi, Kebbi state, NigeriaErhabor Osaro, Usmanu Danfodio University, Nigeria

    17:55-18:15Title: The correlates of novel cardiovascular predictive biomarker: HyperhomocysteinemiaMohamad A. Ayass, Ayass Lung Clinic & Sleep Center, USA

    Panel Discussion18:30-19:30 Cocktails sponsored by Journal of Blood Disorders & Transfusion @ Foyer

    Day 2 September 30, 2014Chesa Peake

    Keynote Forum08:30-08:35 Introduction08:35-09:00 Keith Van Meter Louisiana State University Health Sciences Center, USA09:00-09:25 Effie Liakopoulou Genimbi Inc., USA09:25-09:50 Knox Van Dyke West Virginia University, USA

    09:50-11:50Special session on: Drug Discovery in HematologyChair: Knox Van Dyke, West Virginia University, USA

    Coffee Break 10:30-10:50 @ FoyerSession 3:Track 3: Red Blood CellsSession Chair: Daniel Tsun-Yee Chiu, Chang Gung University, ChinaSession Co-Chair: Volker Blank, McGill University, Canada

    Session Introduction

    11:50-12:10Title: Global metabolic changes and cellular dysfunction in Diamide challenged G6PD-deficient red blood cellsDaniel Tsun-Yee Chiu, Chang Gung University, China

    12:10-12:30Title: Thioredoxin-interacting (TXNIP) protein regulates the differentiation of erythroid precursorsVolker Blank, McGill University, Canada

    Lunch Break 12:30-13:15 @ Edens Landing Restaurant

    13:15-13:35Title: L-Arginine supplementation enhances antioxidant activity and erythrocyte integrity in sickle cell anemia subjectsSmith I Jaja, University of Lagos, Nigeria

    13:35-13:55Title: Osmotic fragility of human erythrocytes in vitro using Vipera lebetina venomNayef S Gharaibeh, Jordan University of Science and Technology, Jordan

    13:55-14:15Title: Role of BMI in predicting prevalence of iron deficiency anemiaNay T. Tun, Easton Hospital, USASymposium on The challenges associated with effective blood transfusion services in developing countriesby Erhabor Osaro, Usmanu Danfodio University, Nigeria

    14:15-14:35Title: Plasmodium parasitaemia among blood donors in Sokoto, North Western NigeriaErhabor Osaro, Usmanu Danfodio University, Nigeria

  • Page 4

    14:35-14:55Title: Pattern of donation and some haematological indices of blood donors in Sokoto, Nigeria. Isaac I Zama, Usmanu Danfodio University, Nigeria

    14:55-15:15Title: Female gender participation in the blood donation process in a resource poor settings: Case study of Sokoto in North Western NigeriaDorcas Ikhuenbor, Usmanu Danfodio University Teaching Hospital, Nigeria

    15:15-15:35Title: Prevalence of Malaria Parasitaemia and methaemoglobin levels among blood donors in Sokoto, NigeriaAugustine Okwesili, Usmanu Danfodio University, Nigeria

    Coffee Break 15:35-15:55 @ Foyer

    15:55-16:15Title: Prevalence of p24 antigen among a cohort of HIV antibody negative blood donors in Sokoto, North Western Nigeria. The question of safety of blood transfusion in NigeriaFestus Aghedo, Usmanu Danfodio University Teaching Hospital, Nigeria

    16:15-16:35Title: Prevalence of high titre alpha and beta haemolysins among blood donors in Sokoto, North Western NigeriaEmmanuel Kufre Uko, University of Calabar, Nigeria

    Session 3:Track 4: Immunology and HematologyTrack 5: Blood TransplantationSession Chair: Ljudmila Stojanovich, Belgrade University, SerbiaSession Co-Chair: Angela F Lukowski, University of California, USA

    Session Introduction

    16:35-16:55Title: Prothrombin time and activated partial thrombin time values among geriatric in national hospital Abuja NigeriaMurna Urna Bivan Ayuba, University of Abuja Teaching Hospital, Nigeria

    16:55-17:15Title: Early iron deficiency and neurocognitive functioning in infancyAngela F Lukowski, University of California, USA

    17:15-17:35Title: The risk of thrombosis in patients with antiphospholipid syndrome: Influence of antiphospholipid antibody type and levelsLjudmila Stojanovich, Belgrade University, Serbia

    17:35-17:55Title: Graft-versus-GVHD, a second transplantation from another donor for the rescue from refractory acute GVHDKazuhiro Ikegame, Hyogo Medical College, Japan

    17:55-18:15Title: An intraosseous blood transfusion, given at a smaller mission hospital, in a critically ill childBritt Gustafsson, Center for Allogeneic Stem Cell Transplantation, Sweden

    Panel Discussion15:00-16:00 Poster presentations @ Foyer18:30-19:30 Cocktails sponsored by Journal of Hematology & Thromboembolic Diseases @ Foyer

    Day 3 October 01, 2014Chesa Peake

    Keynote Forum09:30-09:35 Introduction09:35-10:00 Shimon Slavin The International Center for Cell Therapy & Cancer Immunotherapy, Israel

    Session 4Track 6: Research on Various Blood DisordersTrack 7: Diagnosis, Treatment and Management of Blood DisordersSession Chair: John S Pixley, University of Nevada, USASession Co-Chair: Yolanda Fortenberry, Johns Hopkins University, USA

    Session Introduction

    10:00-10:20Title: Generation of long-term human pancreatic islet cell activity in vivo by induction of immune tolerance to human stem cells John S Pixley, University of Nevada SOM, USA

    10:20-10:40Title: Whole genome methodology for in silico quantification of intratumor heterogeneity: Model for clinical applications in the treatment of patients with hematological malignanciesEffie Liakopoulou, University of Washington, USA

    Coffee Break 10:40-11:00 @ Foyer

    11:00-11:20Title: Characterization of antithrombin-specific RNA aptamers for use in

Recommended

View more >